The Effect of Inspiratory Muscle Training and Breathing Exercises Combined With Upper Extremity and Trunk in Patients With Sarcoidosis
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Nov 21, 2019
Trial Information
Current as of June 18, 2025
Completed
Keywords
ClinConnect Summary
Patients who are in stage II-III with sarcoidosis diagnosed pulmonary involvement who are admitted to the Department of Chest Diseases of Cerrahpaşa Medical Faculty Hospital of Istanbul University will be included in the 30-70 age group 6 months after systemic treatment or no treatment. Patients with stages I and IV, malignancy, heart failure, orthopedic problems and who have to undergo systemic sarcoidosis treatment during the study will not be included in the study. Thirty-four patients who meet the inclusion criteria will be included in the study by signing the informed consent form. In ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The study was conducted in Istanbul University Cerrahpaşa Medical Faculty Hospital Pulmonary Diseases Department with sarcoidosis diagnosed with pulmonary involvement in stage II-III,
- • 6 months after receiving systemic treatment or no treatment.
- Exclusion Criteria:
- • Patients with stage I and IV,
- • malignancy,
- • heart failure,
- • orthopedic problems
- • who had to undergo systemic sarcoidosis treatment during the study
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edirne, Istanbul, Turkey
Patients applied
Trial Officials
Rengin DEMİR
Study Director
counselor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials